Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
- 20 March 2007
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (4), 510-514
- https://doi.org/10.1111/j.1440-1746.2007.04833.x
Abstract
Although nonalcoholic fatty liver disease (NAFLD) is very common among morbidly obese patients, the effect of weight loss after bariatric surgery on inflammation and fibrosis related to NAFLD is still a matter of debate. The aim of this study was to evaluate the impact of Roux-en-Y gastric bypass (RYGB) surgery on NAFLD with a follow up of 2 years. Eighteen consecutive NAFLD patients with body mass index >40 kg/m(2) undergoing gastroplasty with RYGB were enrolled, and wedge liver biopsy was obtained at the operation. After 2 years, these patients underwent percutaneous liver biopsy. At baseline, 67% of patients had nonalcoholic steatohepatitis (NASH) and 33% had steatosis, according to the NASH Clinical Research Network Scoring System (NAS) for biopsy. Cirrhosis was present in 5.5% of the patients with NASH. After a mean excess weight loss of 60%, steatosis disappeared in 84% and fibrosis disappeared in 75% of the patients. Hepatocellular ballooning disappeared in 50%. A slight lobular inflammatory infiltrate remained in 81%, apparently unrelated to fatty degeneration. As liver biochemical variables had been found within normal limits in 92.3% of patients at initial biopsy, no difference was found 2 years later. Lipid profile and blood sugar plasma concentration were closer to normal in all patients after 2 years (P < 0.05). Aspects of NAFLD including steatohepatitis improved significantly with massive weight loss at 2 years after RYGB surgery. No patient in this series had progression of hepatic fibrosis.Keywords
This publication has 23 references indexed in Scilit:
- Lipid Peroxidation in Bariatric Candidates with Nonalcoholic Fatty Liver Disease (NAFLD) – Preliminary FindingsObesity Surgery, 2005
- Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?Diabetes Care, 2004
- Long term prognosis of fatty liver: risk of chronic liver disease and deathGut, 2004
- Non-alcoholic fatty liver disease: an emerging pathological spectrumVirchows Archiv, 2004
- Prevalence of Non-alcoholic Steatohepatitis in Morbidly Obese Subjects Undergoing Gastric BypassObesity Surgery, 2003
- Recommendations for Reporting Weight LossObesity Surgery, 2003
- Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis?Obesity Surgery, 2001
- The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitusJournal of Gastrointestinal Surgery, 1997
- Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome. The Oslo Diet and Exercise Study: a randomized trialDiabetes Care, 1997
- The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 yearsHepatology, 1990